AI
AI

Tag: Pfizer

Pfizer (PFE) Q1 2025 Earnings Report

Photo credit: www.cnbc.com The Pfizer logo is prominently displayed at the pharmaceutical company's manufacturing facility in Newbridge, Ireland, on February...

Why Pfizer Shares Outperformed the Market on Tuesday

Photo credit: www.fool.com On Tuesday, shares of the prominent pharmaceutical firm Pfizer (PFE 1.51%) saw an uptick as investors capitalized...

Pfizer Faces Setback in Obesity Drug Development as GLP-1 Trial is Stopped

Photo credit: finance.yahoo.com Pfizer Halts Phase Three Trial of Danuglipron Pfizer has announced the suspension of its late-stage trial for the...

Pfizer Suspends Obesity Drug Development Following Patient’s Reported ‘Liver Injury’

Photo credit: www.investopedia.com Key Takeaways Pfizer has announced its decision to halt the development of danuglipron, an oral daily weight-loss medication,...

Pfizer Discontinues Daily Weight Loss Pill Danuglipron Due to Liver Injury Concerns

Photo credit: www.cnbc.com Pfizer announced on Monday its decision to discontinue the development of its investigational daily weight loss pill...

Pfizer, Spire, and TriCo Bancshares: Reliable Sources of Profit

Photo credit: finance.yahoo.com Seeking Reliable Yields: Pfizer, Spire, and TriCo Bancshares Shine in Dividend Payments For investors looking for stable sources...

Is Pfizer Inc. (PFE) the Top Affordable Dividend Stock to Invest in Today?

Photo credit: finance.yahoo.com In a recent analysis, we explored the status of Pfizer Inc. (NYSE:PFE) in relation to a curated...

Comparing High-Yield Dividend Stocks: Pfizer vs. Merck

Photo credit: www.fool.com For investors seeking to enhance their passive income, the pharmaceutical sector presents intriguing opportunities. Currently, shares of...

Pfizer (PFE) Q4 2024 Earnings Report

Photo credit: www.cnbc.com At The Wall Street Journal’s Future of Everything Festival held in New York City on May 22,...

Got $200? Here Are 2 Dividend Stocks to Buy and Hold for Life!

Photo credit: finance.yahoo.com Investing in the Pharmaceutical Sector: A Look at Pfizer and Johnson & Johnson As one of the linchpins...

Pfizer Plans to Sell 7.7% Stake in Haleon for Up to $3.1 Billion, According to Bloomberg Reports from Investing.com

Photo credit: www.investing.com Pfizer to Execute Major Share Sale in Haleon Plc Investing.com reports that Pfizer Inc. (NYSE: PFE) is set...

Pfizer Fully Committed to Obesity Drug Development, Says CEO Bourla – Reuters

Photo credit: www.investing.com Pfizer Intensifies Focus on Obesity Drug Development At the recent JPMorgan Healthcare Conference, Pfizer’s CEO Albert Bourla announced...